Anjana Pillai to Liver Transplantation
This is a "connection" page, showing publications Anjana Pillai has written about Liver Transplantation.
Connection Strength
8.205
-
Geographic opportunities for growth in the transplant hepatology training workforce. Liver Transpl. 2024 Oct 01; 30(10):1091-1094.
Score: 0.554
-
Evolving challenges with long-term care of liver transplant recipients. Clin Transplant. 2023 10; 37(10):e15085.
Score: 0.527
-
Many transplant hepatology graduates feel unprepared for first job search: Results from a national employment survey of early career hepatologists. Liver Transpl. 2023 12 01; 29(12):1332-1336.
Score: 0.522
-
CAQ Corner: Evaluation and management of living liver donors. Liver Transpl. 2023 10 01; 29(10):1118-1128.
Score: 0.520
-
Perspective: Advances in liver transplantation for hepatocellular carcinoma - A prototype for transplant oncology. Hepatobiliary Pancreat Dis Int. 2023 02; 22(1):4-6.
Score: 0.495
-
Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care. Liver Transpl. 2022 10; 28(10):1651-1663.
Score: 0.484
-
The New Era of Liver Transplantation for Cholangiocarcinoma: No Longer Just a 1-Man Show. Liver Transpl. 2022 03; 28(3):355-356.
Score: 0.470
-
The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant. 2021 06 01; 26(3):339-345.
Score: 0.453
-
Positron Emission Tomography With Computed Tomography as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma: Ready for Prime Time? Liver Transpl. 2020 06; 26(6):746-747.
Score: 0.420
-
Mixed Hepatocellular-Cholangiocarcinoma: Is It Time to Rethink Consideration for Liver Transplantation? Liver Transpl. 2018 10; 24(10):1329-1330.
Score: 0.376
-
Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin. Aliment Pharmacol Ther. 2017 06; 45(11):1427-1432.
Score: 0.340
-
Management of de novo malignancies after liver transplantation. Transplant Rev (Orlando). 2015 Jan; 29(1):38-41.
Score: 0.288
-
Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C. Transplant Proc. 2010 Nov; 42(9):3647-51.
Score: 0.218
-
Overview of immunosuppression in liver transplantation. World J Gastroenterol. 2009 Sep 14; 15(34):4225-33.
Score: 0.201
-
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun. 2024 06 01; 8(6).
Score: 0.139
-
Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation. Am J Transplant. 2024 Sep; 24(9):1567-1572.
Score: 0.139
-
Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transpl. 2024 Aug 01; 30(8):848-861.
Score: 0.137
-
Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis. Liver Transpl. 2024 Jun 01; 30(6):595-606.
Score: 0.137
-
Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14968.
Score: 0.129
-
Financial, policy, and ethical barriers to the expansion of living donor liver transplant: Meeting report from a living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14955.
Score: 0.128
-
Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in culture. Clin Transplant. 2023 07; 37(7):e14953.
Score: 0.128
-
A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clin Transplant. 2023 07; 37(7):e14967.
Score: 0.128
-
Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14954.
Score: 0.128
-
Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices. Liver Transpl. 2023 06 01; 29(6):591-597.
Score: 0.127
-
Practice patterns of the medical evaluation of living liver donors in the United States. Liver Transpl. 2023 02 01; 29(2):164-171.
Score: 0.127
-
Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States. Am J Gastroenterol. 2022 09 01; 117(9):1530-1535.
Score: 0.123
-
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes. Liver Transpl. 2021 07; 27(7):1019-1031.
Score: 0.114
-
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years? Clin Liver Dis. 2020 11; 24(4):681-700.
Score: 0.109
-
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant. 2021 03; 21(3):1039-1055.
Score: 0.107
-
Liver transplantation for hepatocellular carcinoma: Management after the transplant. Am J Transplant. 2020 02; 20(2):333-347.
Score: 0.102
-
Goals and targets for personalized therapy for HCC. Hepatol Int. 2019 Mar; 13(2):125-137.
Score: 0.096
-
Liver Transplantation in the Obese Cirrhotic Patient. Transplantation. 2017 10; 101(10):2288-2296.
Score: 0.088
-
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience. Am J Gastroenterol. 2016 Feb; 111(2):250-60.
Score: 0.078
-
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015 May; 15(5):1162-72.
Score: 0.073